59 results
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
10 Jun 24
Other Events
6:05am
: Friedreich's ataxia
Nomlabofusp Selected by FDA for START Pilot Program Highlights FDA commitment to augment formal meetings with more rapid, ad-hoc
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
30 May 24
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia
4:08pm
the commitment of the FDA to augment currently available formal meeting communications with more rapid, ad-hoc communication mechanisms with the goal
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
in the biotechnology or healthcare fields;
Personal integrity and ethical character, commitment and independence of thought and judgment;
Capability to fairly … its committees and their activities to support its commitment. Our Board supports management’s promotion of a corporate culture of integrity, ethical
8-K
EX-99.1
xf06slhzc664
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-10.3
drvig8w0e2x3syx4bn8
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.1
cj59v6zpbqigd8s4vm
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-99.2
lopbowp jzyey6m
11 May 21
Other Events
8:34am
8-K
EX-99.1
yps m47qzr
4 Mar 21
Larimar Therapeutics Reports Fourth Quarter and Full Year 2020 Operating and Financial Results
7:30am
8-K
EX-99.2
grty26dm20
8 Dec 20
Regulation FD Disclosure
7:40am
8-K
EX-14.1
rahttpe7gvs
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.1
oj0wjjlvnqiofd
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am